Quarterly report pursuant to Section 13 or 15(d)

REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details)

v3.24.1.1.u2
REVENUES FROM CONTRACTS WITH CUSTOMERS - Disaggregation of net revenues (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Total product revenues $ 13,030 $ 12,165
Qbrexza    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Total product revenues 5,017 4,094
Accutane    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Total product revenues 5,819 4,648
Amzeeq    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Total product revenues 755 1,193
Zilxi    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Total product revenues 273 314
Other / legacy    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Total product revenues $ 1,166 $ 1,916